Savara (SVRA) Shares Issued (2011 - 2026)

Savara (SVRA) reported Shares Issued of $45000.0 for Q1 2026, down 72.73% year-over-year from $165000.0 in Q1 2025, and down 61.54% quarter-over-quarter from $117000.0 in Q4 2025.

Savara (SVRA) Shares Issued (2011 - 2026) Analysis & Trends

Savara (SVRA) has 14 years of Shares Issued data on file, last reported at $45000.0 in Q1 2026.

  • Shares Issued for Q1 2026 came in at $45000.0, down 72.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $227000.0 (up 87.6% YoY), and the FY2025 annual result was $347000.0, up 4857.14% from the prior year.
  • Shares Issued retreated to $45000.0 in Q1 2026 per SVRA's latest filing, from $117000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $237000.0 in Q3 2024 and troughed at -$292000.0 in Q4 2024.
  • A 4-year average of $56833.3 and a median of $64000.0 in 2023 frame the typical range for Shares Issued.
  • The sharpest annual moves came in 2024 and 2025: Shares Issued tumbled 428.09% in 2024, then soared 490.91% in 2025.
  • A 4-year view of Shares Issued shows it stood at $89000.0 in 2023, then plunged by 428.09% to -$292000.0 in 2024, then jumped by 140.07% to $117000.0 in 2025, then sank by 61.54% to $45000.0 in 2026.
  • Business Quant data shows SVRA's Shares Issued at $45000.0 in Q1 2026, $117000.0 in Q4 2025, and $65000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 5.40 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 27.00 Mn
9 Abivax 90.15 Bn 90.15 Bn - 26,927.15
10 Savara 1.33 Bn 1.33 Bn - 45,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 45,000.00
Mar 31, 2026 45,000.00
Dec 31, 2025 117,000.00
Dec 31, 2025 117,000.00
Jun 30, 2025 65,000.00
Jun 30, 2025 65,000.00
Mar 31, 2025 165,000.00
Mar 31, 2025 165,000.00
Dec 31, 2024 -292,000.00
Dec 31, 2024 -292,000.00
Sep 30, 2024 237,000.00
Sep 30, 2024 237,000.00
Jun 30, 2024 11,000.00
Jun 30, 2024 11,000.00
Mar 31, 2024 51,000.00
Mar 31, 2024 51,000.00
Dec 31, 2023 89,000.00
Dec 31, 2023 89,000.00
Sep 30, 2023 63,000.00
Sep 30, 2023 63,000.00